Paul Kenworthy, M.D., today announced that his 200th patient has been treated with the UroLift® System, a proven, minimally invasive technology to treat men suffering from symptoms associated with Benign Prostatic Hyperplasia, or BPH. Dr. Kenworthy is the first physician in Houston and second in Texas, to reach this milestone, performing more UroLift System procedures than any other doctor in the area.
To schedule a consultation with Dr. Kenworthy, please call 281-404-3000.
NeoTract’s FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.
The Northwoods Urology philosophy is centered on three words: progressive, innovative and compassionate. Northwoods Urology is a team of Urologists with convenient locations so we can better serve your community. Learn more at https://www.northwoodsurology.com.
1 Roehrborn et al. EAU Abstract_ Eur Urol Suppl 2017; 16(3):e192.
2 Sonksen et al J Urology 2016